The 3E10-3G5 bispecific antibody retains cell-penetrating and MDM2-binding activities, increases tumor p53 expression, and inhibits the growth of MDM2-associated tumors (Weisbart et al., 2012) (Figure 4). This evidence concerns the gene MDM2 and neoplasm.